Please login to the form below

Not currently logged in
Email:
Password:

memantine

This page shows the latest memantine news and features for those working in and with pharma, biotech and healthcare.

Roche and Evotec’s Alzheimer’s drug ineffective

Roche and Evotec’s Alzheimer’s drug ineffective

disease – the cholinesterase inhibitors donepezil, galantamine and rivastigmine or glutamate NMDA receptor antagonist memantine.

Latest news

More from news
Approximately 0 fully matching, plus 36 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics